The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

U.S. Health Secretary Robert F. Kennedy Jr. is pulling the plug on $500 million in federal funding for mRNA vaccine ...

With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...

Texas Democrats have prevented their state’s House of Representatives from moving forward, at least for now, with a redrawn ...

The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to fight respiratory viruses like COVID-19 and the flu. Here's what we know.

Moderna announced Wednesday that the first trial volunteers have received boosters of their COVID-19 vaccine, some of them modified to target a variant.

Moderna reports that it has received full approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Spikevax.

Moderna reports that it has received full approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Spikevax.